Evicenter
MarkdownMedical informationP&T meetings
Deucrictibant (PHA121)

On-demand treatment of hereditary angioedema attacks

Also known as PHA-022121
Manufacturer
Pharvaris
Last updated
209 sources

Product information and disease descriptionPlace of product in therapyDisease descriptionEpidemiology

Prevalence of hereditary angioedema

12 evidence topics · 9 sources

Pooled diagnosed annual prevalence: combined HAE types and 95% confidence interval